Leo Cancer Care
Private Company
Total funding raised: $25M
Overview
Leo Cancer Care is an innovative private company developing a paradigm-shifting approach to radiation therapy by treating patients in an upright position. Their platform includes solutions for both photon and particle (proton) therapy, designed to enhance patient experience, reduce facility costs, and expand access to advanced radiotherapy modalities. The company is in the pre-commercial stage, actively engaging in research partnerships and validation studies with leading cancer centers to bring its systems to market.
Technology Platform
Open-architecture upright patient positioning platform for radiation therapy, compatible with fixed-beam photon and particle sources. Integrates positioning, imaging, and beam delivery for a full treatment solution from simulation to delivery.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes indirectly with giants in radiation oncology like Varian (Siemens Healthineers) and Elekta, who dominate the supine-based linear accelerator market. In proton therapy, competes with IBA, Varian, and Mevion (also a partner) on gantry-based systems. Leo's differentiation is its exclusive focus on the upright paradigm and open-platform architecture.